Cargando…

Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era

Detalles Bibliográficos
Autores principales: Kawajiri, A, Maruyama, D, Maeshima, A M, Nomoto, J, Makita, S, Kitahara, H, Miyamoto, K-i, Fukuhara, S, Suzuki, T, Munakata, W, Tajima, K, Itami, J, Taniguchi, H, Kobayashi, Y, Tobinai, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056978/
https://www.ncbi.nlm.nih.gov/pubmed/27689743
http://dx.doi.org/10.1038/bcj.2016.88
_version_ 1782458974347460608
author Kawajiri, A
Maruyama, D
Maeshima, A M
Nomoto, J
Makita, S
Kitahara, H
Miyamoto, K-i
Fukuhara, S
Suzuki, T
Munakata, W
Tajima, K
Itami, J
Taniguchi, H
Kobayashi, Y
Tobinai, K
author_facet Kawajiri, A
Maruyama, D
Maeshima, A M
Nomoto, J
Makita, S
Kitahara, H
Miyamoto, K-i
Fukuhara, S
Suzuki, T
Munakata, W
Tajima, K
Itami, J
Taniguchi, H
Kobayashi, Y
Tobinai, K
author_sort Kawajiri, A
collection PubMed
description
format Online
Article
Text
id pubmed-5056978
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-50569782016-10-24 Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era Kawajiri, A Maruyama, D Maeshima, A M Nomoto, J Makita, S Kitahara, H Miyamoto, K-i Fukuhara, S Suzuki, T Munakata, W Tajima, K Itami, J Taniguchi, H Kobayashi, Y Tobinai, K Blood Cancer J Letter to the Editor Nature Publishing Group 2016-09 2016-09-30 /pmc/articles/PMC5056978/ /pubmed/27689743 http://dx.doi.org/10.1038/bcj.2016.88 Text en Copyright © 2016 The Author(s) http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
Kawajiri, A
Maruyama, D
Maeshima, A M
Nomoto, J
Makita, S
Kitahara, H
Miyamoto, K-i
Fukuhara, S
Suzuki, T
Munakata, W
Tajima, K
Itami, J
Taniguchi, H
Kobayashi, Y
Tobinai, K
Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era
title Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era
title_full Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era
title_fullStr Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era
title_full_unstemmed Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era
title_short Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era
title_sort impact of the double expression of myc and bcl2 on outcomes of localized primary gastric diffuse large b-cell lymphoma patients in the rituximab era
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5056978/
https://www.ncbi.nlm.nih.gov/pubmed/27689743
http://dx.doi.org/10.1038/bcj.2016.88
work_keys_str_mv AT kawajiria impactofthedoubleexpressionofmycandbcl2onoutcomesoflocalizedprimarygastricdiffuselargebcelllymphomapatientsintherituximabera
AT maruyamad impactofthedoubleexpressionofmycandbcl2onoutcomesoflocalizedprimarygastricdiffuselargebcelllymphomapatientsintherituximabera
AT maeshimaam impactofthedoubleexpressionofmycandbcl2onoutcomesoflocalizedprimarygastricdiffuselargebcelllymphomapatientsintherituximabera
AT nomotoj impactofthedoubleexpressionofmycandbcl2onoutcomesoflocalizedprimarygastricdiffuselargebcelllymphomapatientsintherituximabera
AT makitas impactofthedoubleexpressionofmycandbcl2onoutcomesoflocalizedprimarygastricdiffuselargebcelllymphomapatientsintherituximabera
AT kitaharah impactofthedoubleexpressionofmycandbcl2onoutcomesoflocalizedprimarygastricdiffuselargebcelllymphomapatientsintherituximabera
AT miyamotoki impactofthedoubleexpressionofmycandbcl2onoutcomesoflocalizedprimarygastricdiffuselargebcelllymphomapatientsintherituximabera
AT fukuharas impactofthedoubleexpressionofmycandbcl2onoutcomesoflocalizedprimarygastricdiffuselargebcelllymphomapatientsintherituximabera
AT suzukit impactofthedoubleexpressionofmycandbcl2onoutcomesoflocalizedprimarygastricdiffuselargebcelllymphomapatientsintherituximabera
AT munakataw impactofthedoubleexpressionofmycandbcl2onoutcomesoflocalizedprimarygastricdiffuselargebcelllymphomapatientsintherituximabera
AT tajimak impactofthedoubleexpressionofmycandbcl2onoutcomesoflocalizedprimarygastricdiffuselargebcelllymphomapatientsintherituximabera
AT itamij impactofthedoubleexpressionofmycandbcl2onoutcomesoflocalizedprimarygastricdiffuselargebcelllymphomapatientsintherituximabera
AT taniguchih impactofthedoubleexpressionofmycandbcl2onoutcomesoflocalizedprimarygastricdiffuselargebcelllymphomapatientsintherituximabera
AT kobayashiy impactofthedoubleexpressionofmycandbcl2onoutcomesoflocalizedprimarygastricdiffuselargebcelllymphomapatientsintherituximabera
AT tobinaik impactofthedoubleexpressionofmycandbcl2onoutcomesoflocalizedprimarygastricdiffuselargebcelllymphomapatientsintherituximabera